DocGo (NASDAQ:DCGO – Get Free Report) is expected to post its Q3 2025 results after the market closes on Monday, November 10th. Analysts expect DocGo to post earnings of ($0.09) per share and revenue of $69.9620 million for the quarter. DocGo has set its FY 2025 guidance at EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Monday, November 10, 2025 at 5:00 PM ET.
DocGo (NASDAQ:DCGO – Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.05). The company had revenue of $80.42 million for the quarter, compared to the consensus estimate of $77.58 million. DocGo had a negative return on equity of 3.26% and a negative net margin of 4.20%. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
DocGo Stock Up 3.8%
Shares of DocGo stock opened at $1.09 on Monday. DocGo has a 52 week low of $1.04 and a 52 week high of $5.68. The business has a 50 day moving average price of $1.38 and a 200-day moving average price of $1.54. The company has a market cap of $106.61 million, a PE ratio of -5.74 and a beta of 0.93.
Institutional Investors Weigh In On DocGo
Wall Street Analysts Forecast Growth
A number of research firms recently commented on DCGO. Zacks Research lowered DocGo from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 7th. Canaccord Genuity Group upped their target price on shares of DocGo from $1.45 to $1.60 and gave the stock a “hold” rating in a research note on Thursday, August 21st. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of DocGo in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $3.24.
Read Our Latest Stock Analysis on DocGo
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories
- Five stocks we like better than DocGo
- How to Choose Top Rated Stocks
- 3 Safe and Steady Stocks for Any Market
- How to Calculate Inflation Rate
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- 3 Dividend Kings To Consider
- Caterpillar Stock Could Top $650 by Year’s End
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
